WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 21-Sep-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 27'1801 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 38'0911 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 46'354  46'348  46'398  46'522  46'698  40'904  39'306  37'797 
Births 399  407  415  424  435  403  404  585 
Surviving infants 398  406  414  423  433  401  401  577 
Pop. less than 5 years 2'017  2'065  2'169  2'239  2'324  1'891  2'108  3'181 
Pop. less than 15 years 6'808  6'849  6'917  6'932  6'948  6'034  7'859  9'795 
Female 15-49 years 10'314  10'445  10'583  10'770  10'968  10'612  9'810  9'006 

Number of reported cases

(Click for retrospective incidence data for Spain)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  161  37  115  154  131  152  21'650  145'322 
Mumps
ChartChart
  10'082  4'999  13'951  9'391 
Pertussis
ChartChart
  4'633  4'892  2'342  921  10'075 
Polio*
ChartChart
  17 
Rubella
ChartChart
  345 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  13  27  54  500 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Spain)
Vaccine year result method % card seen                                                
BCG         
DTP1          98 
DTP3          98  97  97  97  96  95  86 
DTP4          94  95  95  95 
IPV1          98 
HepB_BD          97 
HepB3          93  97  97  96  95  77 
Hib3          98  97  97  97  96  92 
JapEnc         
MCV1          97  97  96  96  95  94  99 
MCV2          93  95  95  93  91 
MenA         
PCV1         
PCV2          94 
PCV3          87  86 
Pol3          94  97  97  97  96  95  94 
Rota1         
RotaC         
RCV1          97  97  96  96  95 
TT2plus          80 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Spain)
DTP1
ChartChart
  98  98  98  98  98  98  95 
DTP3
ChartChart
  98  97  97  97  96  95  86 
HepB3
ChartChart
  93  97  97  96  95  77 
HepB_BD
ChartChart
  52 
Hib3
ChartChart
  98  97  97  96  96  92 
MCV1
ChartChart
  96  97  96  96  95  94  99 
MCV2
ChartChart
  93  95  94  93  91 
PCV3
ChartChart
 
Pol3
  94  97  97  97  96  95  94 
RCV1
ChartChart
  96  97  96  96  95  94  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 19  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 84
From 80 to 89% 16
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
CHOLERA Yes travellers
DTaPHibHepBIPV 2, 4, 11 months; Yes
DTaPHibHepIPV 2, 6 months; Yes
DTaPHibIPV 4, 18 months; Yes
HepA_Adult Yes risk groups
HepA_Pediatric No one region; two cities (Ceuta and Melilla); risk groups in all regions
HepB_Adult Yes risk groups
HepB_Pediatric birth; Yes mothers with AgHBs+
HPV 12 years (x2); Yes females
Influenza_Adult >=65 years; Yes and adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities, other risk groups
Influenza_Pediatric Yes children with chronic illness
IPV Yes travellers
JE_Inactd Yes travellers
MenACWY-135 conj Yes travellers
MenC_conj 4,12 months; Yes
MMR 12 months; 3-4 years; Yes
Pneumo_conj 2, 4, 11 months; Yes risk groups
Pneumo_ps >64 years; Yes risk groups
Td 14 years; Yes >=Y65; wound prophylaxis; adults without vaccination history
Tdap years; Yes pregnant women
Typhoid Yes travellers
Varicella 15 months; 3-4 years; Yes and susceptible adolescentand susceptible adolescents
YF Yes travellers

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  NA  NA  NA 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 19  19  19  19  19  19  19 
Nº districts with DTP3 coverage >=80% number 19  19  19  19  19  19  17 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  89 
Nº districts with measles (MCV1) coverage >=95% number 16  16  16  16  15  15  15 
% of districts with MCV1 coverage >=95% From 0 to 100% 84  84  84  84  79  79  79 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%            

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.